GlassScriptPhysician profile
William H Holmes
NPI 1477586360
$3,219.08
in general payments reported to CMS, 2019-2025
15 companies · $788 in 2025
The $788 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $198 · 2021: $422 · 2022: $420 · 2023: $554 · 2024: $678 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,020.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $757.16 | 2022-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $501.55 | 2022-2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $454.65 | 2019-2021 | |
| Sight Sciences, INC. | $295.49 | 2023-2025 | Tearcare System, Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $244.93 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $233.35 | 2020-2022 | |
| Lkc Technologies, INC. | $137.56 | 2025 | |
| Abb Con-Cise Optical Group LLC | $132.57 | 2022-2025 | Contact Lens, Spectacle Lenses |
| Glaukos Corporation | $106.68 | 2021 | |
| Sun Pharmaceutical Industries INC. | $96.14 | 2024 | |
| Rxsight INC | $82.59 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Novartis Pharmaceuticals Corporation | $71.23 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $49.41 | 2023 | Tecnis Iol |
| Maculogix, INC. | $41.00 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $14.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.